Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin
- 1 July 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (1) , S25-S30
- https://doi.org/10.1016/0002-9343(91)90053-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemiaThe American Journal of Medicine, 1991
- Expanded clinical evaluation of lovastatin (EXCEL) study results II. Assessment of the human lens after 48 weeks of treatment with lovastatinThe American Journal of Cardiology, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Expanded clinical evaluation of lovastatin (EXCEL) study: Design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemiaThe American Journal of Cardiology, 1990
- Clinical experience with lovastatinThe American Journal of Cardiology, 1990
- LovastatinCardiovascular Drug Reviews, 1989
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary HypercholesterolemiaPublished by American Medical Association (AMA) ,1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- 3-Hydroxy-3-Methylglutaryl—Coenzyme A Reductase Inhibitors in the Treatment of HypercholesterolemiaJAMA, 1987